The manuscript summarizes current approved contrast media and their indications. Contrast agents that are discussed include iodinated contrast agents, magnetic resonance (MR) contrast agents, and ultrasound contrast agents. Allergic and non-allergic renal adverse events are described. The clinical issue of metformin and the administration of contrast agents are updated. Nephrogenic systemic fibrosis (NSF) is discussed and safety issues of available MR contrast agents are analyzed. The most recent changes in European Society of Urogenital Radiology (ESUR) guidelines are also presented.
P Reimer, R Vosshenrich. Contrast agents in radiology: current agents approved, recommendations, and safety aspects]. Der Radiologe. 2013 Feb;53(2):153-64
PMID: 23340684
View Full Text